Top in hem/onc: Aspirin and cancer, breast implants and lymphoma

A new study showed that aspirin use may accelerate the progression of cancer among older adults. It was the top story in hematology/oncology last week.

Another top story was about an FDA analysis that revealed a nearly 28% increase in lymphoma cases associated with breast implants in the second half of 2019.

Read these and more top stories in hematology/oncology below:

Aspirin may accelerate cancer progression in older individuals

Aspirin may accelerate the progression of cancer among older people, according to results of a randomized study published in Journal of the National Cancer Institute. Read more.

FDA identifies more cases of lymphoma linked to breast implants

The number of lymphoma cases linked to breast implants increased nearly 28% in the second half of last year, according to the FDA. Read more.

Inspiring Change and Innovation in Medicine

In this episode of Healio’s Oncology Overdrive podcast, Sasha K. Shillcutt, MD, MS, FASE, cardiac anesthesiologist, published author and founder of Brave Enough, discusses the importance of finding our authentic selves, inspiring change and caring for each other in medicine. Read more.

Pembrolizumab regimen extends survival in advanced esophageal cancer

The addition of pembrolizumab (Keytruda, Merck) to first-line chemotherapy extended overall survival and progression-free survival among patients with locally advanced or metastatic esophageal cancer, according to the agent’s manufacturer. Read more.

Women in Medicine Summit highlights practical strategies to advance gender equity

This year’s Women in Medicine Summit will take place in a virtual format on Oct. 9-10. Healio will serve as the official media partner for the CME conference, designed to amplify the lives of women in medicine and work toward gender parity in health care. Read more.